{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.162","meta":{"versionId":"6","lastUpdated":"2021-05-21T01:00:57.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.162","version":"20210521","name":"Elotuzumab Injectable","status":"active","date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1726110","display":"elotuzumab 300 MG Injection"},{"code":"1726117","display":"elotuzumab 400 MG Injection"}]}]},"expansion":{"identifier":"urn:uuid:53a09c75-16bd-4c85-92ec-1f73d1a81bd7","timestamp":"2022-06-10T07:20:08-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1726110","display":"elotuzumab 300 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1726117","display":"elotuzumab 400 MG Injection"}]}}